european patent, page-17

abdm,

"Keeping this research at the lower end of the scale" suggests to me that it is at the bottom of OBJ's activities, yet you provided a long list of products, implying that OBJ was actively pursuing something along those lines. If Glyn says it's not a priority, then we can basically forget about it, right? Given the long timelines for biotech, when something is not a priority, then I think we should forget it. When I read OBJ threads on HC, it seems that OBJ has its finger in every pie. It looks like compensation - OBJ tells us nothing, so posters fill in the space. It creates a false impression of where OBJ is at, imo.

Ramses,

Critiquing claims and suggestions is worthwhile. This forum could do with more critical thinking and a scientific attitude. You suggested that people should sell their houses and put the money on OBJ based on the research presented on these threads. That is irresponsible and one-sided. We need balance in this forum.